A New Class of Therapeutics Could End Immunosuppressants
Amid growing evidence and a Nobel Prize win, research on regulatory T cells could transform treatment for autoimmune disease and transplant rejection, among many other conditions. Medscape Medical…
Read the full articleYou might also wanna read
A revolutionary cancer treatment could transform autoimmune disease
Researchers are testing CAR T cell therapy as a way to reset the immune system in lupus, Graves’ disease and other conditions where the body
The Future of Cancer Treatment May Depend on Making Existing Drugs Work Better Together
While the search for novel therapeutics remains essential, researchers are placing greater emphasis on understanding how the immune system c
Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells
Deep phenotyping reveals that CD19-CAR T cell therapy in SSc patients shows potential in reversing skin fibrosis. Explore how molecular insi
New first-in-human study explores immune-engineered cell therapy ...
The study addresses one of the field's central challenges: overcoming immune rejection, which has limited the broader use of islet and stem
Resetting autoimmune disease with CAR cell therapies
Explore the potential of CAR T cells in autoimmune diseases: a novel way to target B cells, reset immunity, and meet clinical gaps! PMID:421
New first-in-human study explores immune-engineered cell therapy approach for type 1 diabetes
New research presented at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting explores an approach that could expan
Comments
Sign in to join the conversation.
No comments yet. Be the first.